SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001078782-21-000582
Filing Date
2021-06-22
Accepted
2021-06-22 17:15:23
Documents
2
Period of Report
2021-06-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8K CURRENT REPORT f8k061721_8k.htm 8-K 51597
2 EXHIBIT 10.1 2015 STOCK INCENTIVE PLAN, AS AMENDED f8k061721_ex10z1.htm EX-10.1 127046
  Complete submission text file 0001078782-21-000582.txt   180091
Mailing Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY GALLERIA OAKS B, SUITE 125 AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36833 | Film No.: 211036230
SIC: 2835 In Vitro & In Vivo Diagnostic Substances